Breaking News

OctoPlus, Galapagos Sign Manufacturing Contract

OctoPlus N.V. has signed a pharmaceutical development contract with Galapagos N.V.

OctoPlus N.V. has signed a pharmaceutical development contract with Galapagos N.V. OctoPlus will manufacture clinical trial material for Galapagos’ Phase II study of Nanocort, a liposome formulation of prednisolone.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters